JPRN-UMIN000043958已完成未知
Exploratory research of immunochemotherapy for advanced non-small cell lung cancer patients; prospective observation study - Prospective resaerch of immunochemotherapy for advanced NSCLC patients
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Patients with a history of treatment with systemic chemotherapy or immune checkpoint inhibitors (However, molecularly targeted cancer drugs for patients with driver gene mutation positive, and postoperative adjuvant chemotherapy for patients with postoperative recurrence are acceptable) (2)Other patients who are deemed inappropriate by the physician in charge.
研究者
相似试验
已完成
不适用
Clinical study of adjuvant immuno-cell therapy for pancreatic cancer curatively resectable.Pancreatic cancerJPRN-C000000414Yokohama City University Hospital10
已完成
2 期
Phase II study of immunotherapy and cytotoxic agent in combination with palliative radiotherapy in patients with advanced non-small cell lung cancernon-small cell lung cancerJPRN-UMIN000036856Tohoku University Hospital38
已完成
不适用
Explore research of immunochemotherapy for small cell lung cancer patients; prospective observation studySmall cell lung cancerJPRN-UMIN000044048Kyoto Prefectural University of Medicine50
尚未招募
1 期
Gastric cancer immunotherapyIRCT20170208032451N1Mashhad University of Medical Sciences5
已完成
不适用
Phase I/IIa Study of Adoptive Immunotherapy Comprising 2-Methyl-3-Butenyl-1-Pyrophosphate-Stimulated Gamma Delta T Cells in Patients With PSA biochemical failure after radical prostatectomy.JPRN-UMIN000006617Tokyo Women's Medical University10
